Molecular and cellular endocrinology
Other serious but rare side effects include pancreatitis, gallbladder issues, kidney problems, and allergic reactions
tirzepatide to Ozempic vs
They contain the same active ingredient semaglutide, tirzepatide or orforglipron but add minor but clinically important modifications such as using a different salt form, adding different inactive ingredients and varying drug concentrations or dosages
Hypoglycaemia risk: Retatrutide, like other incretin-class agents, stimulates insulin secretion in a glucose-dependent manner, meaning the risk of hypoglycaemia with monotherapy in otherwise healthy individuals is generally low
LY3437943 significantly decreased plasma glucose (blood sugar), HbA1c, and body weight in a dose-dependent manner